Man Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.06M Buy
139,044
+90,265
+185% +$1.34M ﹤0.01% 1209
2025
Q1
$874K Sell
48,779
-39,462
-45% -$707K ﹤0.01% 1407
2024
Q4
$1.54M Buy
88,241
+62,798
+247% +$1.09M ﹤0.01% 1253
2024
Q3
$356K Sell
25,443
-73,219
-74% -$1.02M ﹤0.01% 1601
2024
Q2
$811K Sell
98,662
-18,939
-16% -$156K ﹤0.01% 1431
2024
Q1
$907K Buy
+117,601
New +$907K ﹤0.01% 1469
2023
Q2
Hold
0
-$416K 2178
2023
Q1
Sell
-21,300
Closed -$448K 1560
2022
Q4
$448K Buy
21,300
+2,800
+15% +$58.9K ﹤0.01% 1536
2022
Q3
$456K Buy
+18,500
New +$456K ﹤0.01% 1517
2022
Q2
Sell
-9,500
Closed -$245K 2250
2022
Q1
$245K Buy
+9,500
New +$245K ﹤0.01% 1795
2021
Q1
Sell
-53,777
Closed -$1.47M 1996
2020
Q4
$1.47M Buy
53,777
+200
+0.4% +$5.45K 0.01% 1301
2020
Q3
$989K Buy
53,577
+4,807
+10% +$88.7K ﹤0.01% 1374
2020
Q2
$996K Sell
48,770
-7,207
-13% -$147K 0.01% 1269
2020
Q1
$817K Sell
55,977
-3,635
-6% -$53.1K 0.01% 1156
2019
Q4
$846K Hold
59,612
﹤0.01% 1514
2019
Q3
$691K Sell
59,612
-300
-0.5% -$3.48K ﹤0.01% 1504
2019
Q2
$1.2M Sell
59,912
-1,633
-3% -$32.8K ﹤0.01% 1462
2019
Q1
$1.39M Sell
61,545
-3,067
-5% -$69.4K 0.01% 1465
2018
Q4
$1.46M Sell
64,612
-7,130
-10% -$161K 0.01% 1325
2018
Q3
$2.06M Buy
71,742
+11,455
+19% +$329K 0.01% 1397
2018
Q2
$1.64M Buy
60,287
+7,375
+14% +$201K 0.01% 1428
2018
Q1
$1.18M Buy
+52,912
New +$1.18M 0.01% 1444